Company / Cash per Share
NovoCure Ltd Cash per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$0.86
FY2025
5-year range
$0.86 / $2.29
FY2021-FY2025
Trend
-43.6%
vs FY2024
Sector context
#127 of 150
Health Care
What the data says
NovoCure Ltd's cash per share of $0.86 is lower than 85% of companies in the Health Care sector (FY2025). Cash per Share has fluctuated over the past 10 years, ranging from $0.86 in FY2025 to $2.36 in FY2020.
Based on SEC 10-K filings.
0.86 in FY2025 with a 5-year CAGR of -18.2%.
Declined from $2.29 to $0.86 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -8.1%
- 5-Year CAGR
- -18.2%
- 10-Year CAGR
- -
Sector benchmark
Bottom 15% in Health CareTop 85% of 150This company $0.86 Sector average $27.11
▼
-96.8% below sector average
Key checks
Key Insights
- In FY2025, cash per share decreased 43.6% year-over-year.
- Ranks #127 out of 150 companies in the Health Care sector.
- Peak cash per share was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score -0.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.86 | -43.6% |
| FY2024 | $1.53 | -33.3% |
| FY2023 | $2.29 | +106.7% |
| FY2022 | $1.11 | -45.6% |
| FY2021 | $2.04 | -13.5% |
| FY2020 | $2.36 | +24.0% |
| FY2019 | $1.90 | +21.0% |
| FY2018 | $1.57 | +74.1% |
| FY2017 | $0.90 | -24.2% |
| FY2016 | $1.19 | -86.6% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026